2.7% Above Target

Wall Street's consensus price target for FHI is $57.5, -2.7% from its current price of $59.07. The below-market target from 21 analysts suggests limited near-term appreciation.

FHI has a consensus rating of "Hold" based on 21 Wall Street analysts. The rating breakdown is mixed, with 13 Hold ratings making up the largest segment. The consensus 12-month price target of $57.5 implies -2.7% downside from current levels.

With a forward P/E of 11.5635x, FHI trades at a relatively low valuation. The consensus target of $57.5 implies -2.7% move, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $59 for FHI, while the most conservative target is $56. The consensus of $57.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $99 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

FHI is well covered by analysts, with 21 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 13 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month FHI stock forecast based on 21 Wall Street analysts shows a consensus price target of $57.5, with estimates ranging from $56 (bear case) to $59 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $75, with bear/bull scenarios of $47/$99.

Our quantitative valuation model calculates FHI's fair value at $75 (base case), with a bear case of $47 and bull case of $99. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.

FHI trades at a forward P/E ratio of 11.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 11.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on FHI, with 4 Sell ratings and a price target of $57.5 (-2.7% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

FHI analyst price targets range from $56 to $59, a 5% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $57.5 consensus represents the middle ground. Our model's $47-$99 range provides an independent fundamental perspective.